晨间信号Morning Signal
《新科学家》 第3576期 · 2026年1月3日 · 中文解读

LSD治疗焦虑症:2025年试验结果积极,2027年或获FDA批准

We’ll learn more about LSD and anxiety · Carissa Wong
约 7 分钟News在小程序里点播,20 到 60 分钟做好
这篇讲什么
两项关于迷幻药LSD减轻焦虑的大型试验将于今年结束,此前一项早期试验的成功让科学家们感到乐观,该治疗可能最早于2027年在美国上市。
原文开头
Studies this year could lead to the drug being used as a mental health treatment Carissa Wong “If the results TWO major trials investigating the potential of the psychedelic drug LSD for reducing anxiety are set to conclude this year. Scientists are feeling positive after the drug’s success in an earlier-stage trial, which could mean the treatment will be available in the US as early as 2027. The key difference between the two trials is that the second also has a third group of participants on a 50-microgram dose of LSD. The 2025 trial demonstrated that this dose has mind-altering effects, such as hallucinations, but doesn’t reduce anxiety beyond the placebo effect. …
摘自《新科学家》(New Scientist)第3576期 · 2026年1月3日,Carissa Wong。仅引用开头一小段供了解文章,版权归原刊所有,全文请阅读原刊。
晨间信号小程序码
微信扫码,在小程序里听完整版
不用登录先听一篇 · 或在微信搜索小程序 晨间信号
同期其他文章